218 related articles for article (PubMed ID: 27299983)
1. Neoadjuvant chemotherapy and transoral surgery as a definitive treatment for oropharyngeal cancer: A feasible novel approach.
Sadeghi N; Li NW; Taheri MR; Easley S; Siegel RS
Head Neck; 2016 Dec; 38(12):1837-1846. PubMed ID: 27299983
[TBL] [Abstract][Full Text] [Related]
2. Submandibular gland preservation during concurrent neck dissection and transoral surgery for oropharyngeal squamous cell carcinoma.
Howard BE; Hinni ML; Nagel TH; Chang YH; Cheng MR; Hayden RE
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):587-93. PubMed ID: 24449797
[TBL] [Abstract][Full Text] [Related]
3. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
[TBL] [Abstract][Full Text] [Related]
4. Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach.
Wilkie MD; Upile NS; Lau AS; Williams SP; Sheard J; Helliwell TR; Robinson M; Rodrigues J; Beemireddy K; Lewis-Jones H; Hanlon R; Husband D; Shenoy A; Roland NJ; Jackson SR; Bekiroglu F; Tandon S; Lancaster J; Jones TM
Head Neck; 2016 Aug; 38(8):1263-70. PubMed ID: 27042800
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
Mantz CA; Vokes EE; Stenson K; Kies MS; Mittal B; Witt ME; List MA; Weichselbaum RR; Haraf DJ
Cancer J; 2001; 7(2):140-8. PubMed ID: 11324767
[TBL] [Abstract][Full Text] [Related]
7. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Lörincz BB; Möckelmann N; Busch CJ; Knecht R
Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
[TBL] [Abstract][Full Text] [Related]
8. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
10. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
[TBL] [Abstract][Full Text] [Related]
11. Oncologic results of transoral laser microsurgery for squamous cell carcinoma of the posterior pharyngeal wall.
Canis M; Wolff HA; Ihler F; Matthias C; Steiner W
Head Neck; 2015 Feb; 37(2):156-61. PubMed ID: 24519973
[TBL] [Abstract][Full Text] [Related]
12. A New Clinical Trial of Neoadjuvant Chemotherapy Combined With Transoral Robotic Surgery and Customized Adjuvant Therapy for Patients With T3 or T4 Oropharyngeal Cancer.
Park YM; Jung CM; Cha D; Kim DH; Kim HR; Keum KC; Cho NH; Kim SH
Ann Surg Oncol; 2017 Oct; 24(11):3424-3429. PubMed ID: 28718033
[TBL] [Abstract][Full Text] [Related]
13. Transoral surgery alone for human-papillomavirus-associated oropharyngeal squamous cell carcinoma.
Olsen SM; Moore EJ; Laborde RR; Garcia JJ; Janus JR; Price DL; Olsen KD
Ear Nose Throat J; 2013 Feb; 92(2):76-83. PubMed ID: 23460216
[TBL] [Abstract][Full Text] [Related]
14. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
Smith RV; Schiff BA; Garg M; Haigentz M
Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
[TBL] [Abstract][Full Text] [Related]
16. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
Weinstein GS; Quon H; O'Malley BW; Kim GG; Cohen MA
Laryngoscope; 2010 Sep; 120(9):1749-55. PubMed ID: 20717944
[TBL] [Abstract][Full Text] [Related]
17. Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery.
Grant DG; Hinni ML; Salassa JR; Perry WC; Hayden RE; Casler JD
Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1225-30. PubMed ID: 20026820
[TBL] [Abstract][Full Text] [Related]
18. Salvage transoral robotic surgery in recurrent oropharyngeal carcinoma: a single-center retrospective study.
Ansarin M; Pietrobon G; Tagliabue M; Mossinelli C; Ruju F; Maffini F; Rocca MC; Alterio D; Simon C; Zorzi SF
Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3167-3177. PubMed ID: 38546850
[TBL] [Abstract][Full Text] [Related]
19. Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma.
Park YM; Kim HR; Cho BC; Keum KC; Cho NH; Kim SH
Oral Oncol; 2017 Dec; 75():16-21. PubMed ID: 29224814
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC).
Bußmann L; Laban S; Wittekindt C; Stromberger C; Tribius S; Möckelmann N; Böttcher A; Betz CS; Klussmann JP; Budach V; Muenscher A; Busch CJ
BMC Cancer; 2020 Jul; 20(1):701. PubMed ID: 32727416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]